CIHR Antimicrobial Resistance Research Initiative – Management Action Plan (MAP)

Recommendation #1
CIHR should continue to invest in priority-driven AMR research through the AMRI and assess the level of funding to achieve AMRI expected outcomes and support the federal government AMR research priorities.
Management Response

Agree
Action and Rationale Expected completion/implement ation date Date of Management Action Plan Action Responsibility for Action
In collaboration with partners, CIHR will continue to invest in the AMRI and will align these investments with federal government priorities defined in the 2015 Treasury Board Submission and Pan-Canadian Action Plan on AMR. 2026/27 (ongoing) July 2024
  • Vice-President, Research
  • Director General, Initiative Management and Institute Support and Program Design and Delivery, Initiative Management and Institute Support in collaboration with the Scientific Director, Institute of Infection and Immunity
Recommendation #2
CIHR should be guided by a One Health approach for the AMRI that recognizes the interconnectedness of humans, animals and the environment within health research to address the threat of AMR.
Management Response

Agree
Action and Rationale Expected completion/implement ation date Date of Management Action Plan Action Responsibility for Action

As the AMRI budget allows, CIHR will identify opportunities to invest, through the AMRI and other sources of funding, in funding opportunities that advance human health research using a One Health approach to address the threat of AMR to human health.

CIHR will embed criteria that advance human health research through a One Health approach in AMRI-led funding opportunities through the design of focused objectives, eligibility criteria, evaluation criteria and/or conditions of funding, and in AMRI-funded pools in other funding competitions where possible.

 2026/27 (ongoing) July 2024
  • Vice-President, Research
  • Director General, Initiative Management and Institute Support and Program Design and Delivery, Initiative Management and Institute Support in collaboration with the Scientific Director, Institute of Infection and Immunity
Recommendation #3
CIHR should engage with other federal research funding agencies to better support a One Health approach to AMR research.
Management Response

Agree
Action and Rationale Expected completion/implement ation date Date of Management Action Plan Action Responsibility for Action
CIHR will engage with other federal research funding agencies to better support a One Health approach to AMR research. In collaboration with AAFC, CIHR will identify current and planned One Health- related research activities and opportunities that advance the Government of Canada’s AMR research priorities and deliver a National One Health AMR Research Strategy to PHAC. 2026/27 (ongoing) July 2024
  • Vice-President, Research
  • Director General, Initiative Management and Institute Support and Program Design and Delivery, Initiative Management and Institute Support in collaboration with the Scientific Director, Institute of Infection and Immunity
Recommendation #4
CIHR needs to embed equity, diversity and inclusion considerations as well as engagement with Indigenous communities into all aspects of the AMRI and, by extension, AMR research in general.
Management Response

Agree
Action and Rationale Expected completion/implement ation date Date of Management Action Plan Action Responsibility for Action

CIHR will embed equity, diversity and inclusion considerations in all AMRI-led funding opportunities through the design of focused objectives, eligibility criteria, evaluation criteria and/or conditions of funding, and in AMRI-funded pools in other funding competitions where possible.

CIHR will advance engagement with Indigenous communities, through the development of an Indigenous Engagement Plan as part of the broader National One Health AMR Research Strategy.

 2026/27 (ongoing) July 2024
  • Vice-President, Research
  • Director General, Initiative Management and Institute Support and Program Design and Delivery, Initiative Management and Institute Support in collaboration with the Scientific Director, Institute of Infection and Immunity
Recommendation #5
CIHR should consider a mechanism for external independent advice on AMR Research Priorities as outlined in the program authorities.
Management Response

Agree
Action and Rationale Expected completion/implement ation date Date of Management Action Plan Action Responsibility for Action

CIHR will consider a mechanism for external independent advice on AMR Research Priorities should there be increased ring-fenced budget available for the AMRI.

The SD, III currently provides expert scientific and strategic leadership for the AMRI, and benefits from external expert advice provided through their Institute Advisory Board (IAB),III’s IAB One Health subcommittee and from the JPIAMR board. Given the current budget, this is considered to be appropriate and sufficient, and their approach is considered effective, with positive impacts, as noted in this evaluation.

The development of the National One Health AMR Research Strategy will include external consultations, including with AMR experts, to identify research priorities in AMR. Should AMR RI funding increase substantially, CIHR could seek ongoing external independent advice on priorities from an AMR Advisory Committee.

 2026/27 (ongoing) July 2024
  • Vice-President, Research
  • Director General, Initiative Management and Institute Support and Program Design and Delivery, Initiative Management and Institute Support in collaboration with the Scientific Director, Institute of Infection and Immunity
Date modified: